Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch(University of North Carolina at Chapel Hill), Bryce B. Reeve(University of North Carolina at Chapel Hill), Sandra A. Mitchell(University of North Carolina at Chapel Hill), Steven B. Clauser(University of North Carolina at Chapel Hill), Lori M. Minasian(University of North Carolina at Chapel Hill), Amylou C. Dueck(University of North Carolina at Chapel Hill), Tito R. Mendoza(University of North Carolina at Chapel Hill), Jennifer L. Hay(University of North Carolina at Chapel Hill), Thomas M. Atkinson(University of North Carolina at Chapel Hill), Amy P. Abernethy(University of North Carolina at Chapel Hill), Deborah Watkins Bruner(University of North Carolina at Chapel Hill), Charles S. Cleeland(University of North Carolina at Chapel Hill), Jeff A Sloan(University of North Carolina at Chapel Hill), Ram Chilukuri(University of North Carolina at Chapel Hill), Paul Baumgartner(University of North Carolina at Chapel Hill), Andrea Denicoff(University of North Carolina at Chapel Hill), Diane St Germain(University of North Carolina at Chapel Hill), Ann M. O’Mara(University of North Carolina at Chapel Hill), Alice Chen(University of North Carolina at Chapel Hill), Joseph Kelaghan(University of North Carolina at Chapel Hill), Antonia V. Bennett(University of North Carolina at Chapel Hill), Laura Sit(University of North Carolina at Chapel Hill), Lauren J. Rogak(University of North Carolina at Chapel Hill), A. Barz(University of North Carolina at Chapel Hill), Diane Β. Paul(University of North Carolina at Chapel Hill), Deborah Schrag(University of North Carolina at Chapel Hill)
JNCI Journal of the National Cancer Institute
September 29, 2014
10.1093/jnci/dju244
Cited by 1,112Open Access
Full Text

Abstract

The standard approach for documenting symptomatic adverse events (AEs) in cancer clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) Common Terminology Criteria for Adverse Events (CTCAE). Because this approach underdetects symptomatic AEs, the NCI issued two contracts to create a patient-reported outcome (PRO) measurement system as a companion to the CTCAE, called the PRO-CTCAE. This Commentary describes development of the PRO-CTCAE by a group of multidisciplinary investigators and patient representatives and provides an overview of qualitative and quantitative studies of its measurement properties. A systematic evaluation of all 790 AEs listed in the CTCAE identified 78 appropriate for patient self-reporting. For each of these, a PRO-CTCAE plain language term in English and one to three items characterizing the frequency, severity, and/or activity interference of the AE were created, rendering a library of 124 PRO-CTCAE items. These items were refined in a cognitive interviewing study among patients on active cancer treatment with diverse educational, racial, and geographic backgrounds. Favorable measurement properties of the items, including construct validity, reliability, responsiveness, and between-mode equivalence, were determined prospectively in a demographically diverse population of patients receiving treatments for many different tumor types. A software platform was built to administer PRO-CTCAE items to clinical trial participants via the internet or telephone interactive voice response and was refined through usability testing. Work is ongoing to translate the PRO-CTCAE into multiple languages and to determine the optimal approach for integrating the PRO-CTCAE into clinical trial workflow and AE analyses. It is envisioned that the PRO-CTCAE will enhance the precision and patient-centeredness of adverse event reporting in cancer clinical research.

Related Papers

No related papers found

Powered by citation graph analysis